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Abstract
Background: Reduced nutrient intake is common in patients after hospitalization, contributing to increased risk for readmission
and mortality. Oral nutrition supplements can improve nutrition status and clinical outcomes, but intake of food is prioritized by
clinicians. This study examines the impact of a high-protein oral nutrition supplement (S-ONS) on nutrient intake post discharge.
Methods: In a subset of patients (14 S-ONS and 16 placebo) from the NOURISH (Nutrition effect On Unplanned ReadmIssions
and Survival in Hospitalized patients) trial, 24-hour dietary recalls were conducted on 3 randomly selected days during the weeks
of 30, 60, and 90 days post discharge. Nutrient intake was estimated using Nutrition Data System for Research software. Adequate
energy and protein intake were defined as 30 kcal/kg/d and 1.2 g/kg/d, respectively. Dietary Reference Intakes (DRIs) were used
for other nutrients. Results: Less than half of patients met the requirements for energy, protein, and 12 micronutrients from food
intake alone during the study. Energy and protein intakes from food were not diminished relative to placebo. Considering nutrient
intake from both food and S-ONS, 50% and 71% of patients receiving S-ONSs met energy and protein goals respectively at 90 days
(compared with 29% and 36%, in the placebo group), and 100% met the DRI for total carbohydrate, iron, phosphorus, copper,
selenium, thiamin, and riboflavin at all time points, all of which were consumed at higher amounts vs placebo. Conclusion: Three
months of S-ONS consumption increases intake of numerous nutrients without decreasing nutrient intake from food in older
malnourished adults post discharge. (JPEN J Parenter Enteral Nutr. 2019;43:794–802)
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Clinical Relevancy Statement
This article provides evidence supporting consumption of
oral nutrition supplements (ONSs) in hospitalized older
adults in postdischarge settings to improve overall nutrient
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intake. Routine clinical practice often prioritizes nutrient in-
take in the form of food overONSs; however, this belief may
need to be reassessed. In fact, ONS is an effective interven-
tion to increase intake of numerous macronutrients and mi-
cronutrients without disrupting normal food consumption.
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Background
Malnutrition is a prevalent but underdiagnosed risk factor
associated with poor health outcomes including increased
risk for infection, decreased cardiopulmonary and immune
function, delayed wound healing, and lower activities of
daily living.1-3 Furthermore, malnourished individuals ex-
perience increased hospital length of stay, readmission,
and long-term medical costs, which are associated with
decreased quality of life and increased mortality,2,4-7 par-
ticularly those with cardiopulmonary conditions.7
One-third to one-half of patients are assessed as mal-
nourished at hospital admission.3,5,8-10 Unfortunately, pa-
tients may experience further nutrition decline during
their hospitalization.11,12 This exacerbation is ill addressed.
The Canadian Malnutrition Task Force reported that
at least one-third of patients discharged to home are
malnourished.13 Maeda et al3 reported that nearly two-
thirds of Japanese patients transferred to post–acute care
are malnourished. To further compound these issues, mul-
tiple factors influence reduced food intake and increased
nutrient needs after discharge. These include underlying
illness, anorexia, difficulty preparing and consuming food
independently, and oral problems.14,15
Oral nutrition supplements (ONSs) are developed to help
patients overcome these factors to meet nutrition needs,
thus improving overall nutrition status, quality of life,
and clinical outcomes. Consumption of ONSs, particularly
those with high protein content, improves clinical and
economic outcomes in older patients who are frail, at nutri-
tion risk, and/or have multiple morbidities.16-18 In a review
of 36 randomized controlled trials including 2790 older
patients,18 the use of high-proteinONSs (>20% energy from
protein) reduces complications and readmissions with no
impact on normal food intake. Despite all of this, dietary
planning for the postdischarge period is often deficient,19,20
and <10% of patients receive a prescription for ONS at
discharge.10
Although the importance of meeting energy and protein
goals is a primary clinical focus, intake of micronutrients
also supports patient recovery.18,21,22 There is a dearth of
data on dietary micronutrient consumption in older mal-
nourished patients. The small amount of available data sug-
gests that older adult patients have low vitamin D intake,23
and that those with chronic obstructive pulmonary disease
(COPD) in particular have deficient intake of calcium,
potassium, and vitamins A, D, B1, and B9 as compared with
the recommended daily allowance (RDA).24
To comprehensively assess the effect of ONS on overall
nutrient intake, this analysis examines supplementation of a
high-protein specialized oral nutrition supplement (S-ONS)
on macronutrient and micronutrient intake for 90 days
after hospital discharge. Furthermore, it provides suggested
sample sizes to facilitate design of future studies aiming
to assess nutrient intake and provide targeted nutrition
intervention in older adults.
Methods
Study Design
The data for this analysis were derived from 30 patients
(14 S-ONS and 16 placebo) from the NOURISH (Nu-
trition effect On Unplanned ReadmIssions and Survival
in Hospitalized patients) study cohort.25 The NOURISH
study is a prospective, randomized, double-blind study
that was designed to examine the effect of the S-ONS in
652 malnourished (subjective global assessment B or C)
older adults (65 years of age) hospitalized with chronic
heart failure, acute myocardial infarction, pneumonia, or
COPD (clinicaltrials.gov NCT01626742). Patients with di-
abetes, liver or kidney failure, dementia, or receiving active
cancer treatment were excluded. Detailed inclusion and
exclusion criteria and primary study findings were reported
previously.25
Interventions
Patients who were randomized to the S-ONS group re-
ceived standard of care and a specialized, nutrient-dense,
high-protein, ready-to-drink supplement (Abbott Nutri-
tion, Columbus, OH, USA), 2 servings per day during
hospitalization and up to 90 days after discharge. Each
serving (237 mL) of the S-ONS provided 350 kcal, 20 g of
protein, 11 g of fat, 44 g of carbohydrate, 1.5 g of calcium
β-hydroxy β-methylbutyrate, and 26 essential vitamins and
minerals. Patients in the placebo group received standard
of care and a ready-to-drink liquid (Abbott Nutrition) that
contained 48 kcal, 12 g of carbohydrate, and 10 mg of
vitamin C, but no other macronutrients or micronutrients.
Notably, patients were instructed to consume the supple-
ments between meals, before bed, or each time with oral
medications to minimize impact on regular food intake. As
previously reported, approximately one-third of patients in
both groups reported product consumption of >75% over
the 90-day follow-up period.25
Dietary Data Analysis
After hospital discharge, 24-hour dietary recalls were con-
ducted by phone on 3 randomly selected days (2 weekdays
and 1 weekend day) during the weeks of days 30, 60, and
90 post discharge by the Pennsylvania State University Diet
Assessment Center. The recalls were conducted on unan-
nounced, random, nonconsecutive days, using standardized
multiple-pass methodology and portion size estimation
tools. Nutrient intake was estimated using Nutrition Data
System for Research Version 2012 (University of Min-
nesota, Minneapolis, MN, USA). Because many patients
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found that this procedure was challenging, which impacted
patient retention and study compliance, dietary recall was
terminated after completion of the 30 patients, whose data
were included in this analysis.
Nutrient adequacy was determined as follows: the ad-
equacy of caloric intake was defined as 30 kcal/kg body
weight/d,26 and protein adequacy was defined as 1.2 g/kg
body weight/d27 given the fact that the population was
malnourished, with chronic diseases and acute illness. The
Dietary Reference Intakes (DRIs) were used to assess ade-
quacies of other nutrients.28
Statistical Analyses
Nutrient intakes from the diet (food alone and food +
ONS), as well as percentage of DRIs met from the diet,
were analyzed usingWilcoxon rank sum test to compare the
placebo and S-ONS groups. The proportion of subjects who
met DRIs by nutrient was compared between groups using
Fisher exact test. Within each group, the relationship be-
tween study product consumed vs the number of DRIs met
was modeled using repeated-measures analysis of variance.
P-values  .05 were considered statistically significant. No
adjustment in the significance level formultiplicity of testing
was made for these exploratory outcomes. SAS version 9.4
was used in the analyses.
To facilitate the design of future studies aiming to assess
individual nutrient intake in this diseased population, we
conducted a series of power analyses focusing on individual
nutrients using nQuery Advisor 7.0 with power set at 80%
and statistical significance at .05 using 2-sided t-tests; the
effect sizes appear in Table 3.
Results
Baseline Characteristics
Baseline demographic and clinical characteristics of the
NOURISH population and this subset of patients are pre-
sented in Table 1. For the 30 patients included in the dietary
analysis, age, weight, body mass index, primary diagnosis,
gender, race, marital status, number of household members,
and average household incomewere all comparable between
S-ONS and placebo groups, except for nutrition risk assess-
ment, as measured by subjective global assessment, which
tended to beworse (C status) in the S-ONS group (P= .051).
Patient Compliance
In the subset of patients, the median product consumption
was 1.46 servings/d (first quartile = 0.62, third quartile
= 1.90). The number of supplements consumed was not
significantly different between placebo and S-ONS groups,
or across time points within group (all P > .05).
Nutrient Intake From Food Alone
As expected, most patients did not meet energy or protein
requirements from food alone at any time point (Figure 1A
and 1B). Macronutrient intake from food alone was similar
between the 2 groups except that, at 30 days only, the
proportion of total calories from fat tended to be higher in
the placebo group (P = .052; Figure 1C). As a percentage
of DRI, micronutrient intake from food alone was not
different between placebo and S-ONS groups for most
nutrients (Table 2, Figure 1). However, at 90 days, dietary
intake of the micronutrients iron, magnesium, phosphorus,
zinc, copper, manganese, selenium, vitamin A, vitamin B12,
and choline were higher in the S-ONS treatment group
compared with placebo controls (all P < .05).
It is also important to consider how many patients
actually met or exceeded nutrient intake goals. Reflective of
the percentage of DRI met data, the percentage of patients
meeting most nutrient intake goals from food alone did not
differ between placebo and S-ONS groups (Table S1). The
majority of patients (70%) did not meet energy and protein
goals regardless of treatment group or time point. However,
at 90 days, more patients in the S-ONS treatment group
met the RDA for iron, zinc, manganese, vitamin A, and
vitamin B12 (all P < .05). Notably, no patients in either
group met the RDA for choline (90 days), dietary fiber (60
and 90 days), magnesium (60 and 90 days), potassium (all
days), or vitamin D (all days) from food alone, indicating
that these patients may be at highest risk for deficiency of
these nutrients.
Nutrient Intake From Food and ONSs
As anticipated, nutrient intake from food + S-ONS was
higher for almost all micronutrients as a percentage of DRI
met (Table 2). Exceptions were sodium (all days), choline
(30 days), and vitamin K (30 and 90 days). Macronutrient
intakes of total energy (90 days), protein (60 and 90 days),
dietary fiber (60 and 90 days), linoleic acid (60 and 90 days),
and linolenic acid (all days) were also increased by S-ONS
(Figure 1). Conversely, percent calories from saturated fat
intake was greater in the placebo group at all time points,
whereas total fat was higher at 30 days (Figure 1C) vs the
S-ONS group.
Again considering the proportion of patients who met
the DRI, intake of about one-third of nutrients was im-
proved by S-ONS as indicated by more patients meeting
or exceeding nutrient intake goals (Table S1). Including
nutrient intake from both food and S-ONS within the S-
ONS group, numerically more patients met energy (50%)
and protein (71%) goals compared with food alone (29%
and 36%, respectively) regardless of time. Furthermore,
more patients in the S-ONS group met the DRI for total
fat (30 days) and saturated fat (30 and 90 days). More
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Age, y, mean (SEM) 77.69 (2.49) 76.64 (1.91) 77.20 (1.58) NSD 77.93 (0.34)
Weight, kg, mean (SEM) 61.70 (3.07) 60.84 (3.84) 61.30 (2.39) NSD 66.88 (0.67)
Body mass index, mean (SEM) 22.34 (1.05) 21.85 (1.14) 22.11 (0.76) NSD 24.07 (0.20)
Sex, n (%) NSD
Male 7 (43.8) 7 (50.0) 14 (46.7) 298 (47.9)
Female 9 (56.3) 7 (50.0) 16 (53.3) 324 (52.1)
Race, n (%) NSD
Black/African American 2 (12.5) 1 (7.1) 3 (10.0) 67 (10.8)
White/Caucasian 14 (87.5) 13 (92.9) 27 (90.0) 541 (87.0)
Subjective global assessment, n (%) .051
B 16 (100) 11 (78.6) 27 (90) 543 (87.3)
C 0 (0) 3 (21.4) 3 (10) 79 (12.7)
Primary diagnosis, n (%) NSD
Heart failure 2 (12.5) 1 (7.1) 3 (10.0) 157 (25.3)
Acute myocardial infarction 3 (18.8) 1 (7.1) 4 (13.3) 55 (8.9)
Pneumonia 7 (43.8) 7 (50.0) 14 (46.7) 195 (31.4)
Chronic obstructive pulmonary disease 4 (25.0) 5 (35.7) 9 (30.0) 214 (34.5)
Marital status NSD
Single 1 (6.3) 0 (0.0) 1 (3.3) 71 (11.4)
Married/Common law 6 (37.5) 6 (42.9) 12 (40.0) 234 (37.6)
Divorced/Separated 2 (12.5) 1 (7.1) 3 (10.0) 80 (12.8)
Widowed 7 (43.8) 7 (50.0) 14 (46.7) 237 (38.1)
No. of household members, mean (SD) 2.27 (0.46) 1.86 (0.42) 2.07 (0.31) NSD 1.95 (0.04)
Average household income, n (%) NSD
<$10,000 3 (18.8) 1 (7.1) 4 (13.3) 90 (14.5)
$10,000–$24,999 3 (18.8) 3 (21.4) 6 (20.0) 194 (31.2)
$25,000–$49,999 2 (12.5) 3 (21.4) 5 (16.7) 120 (19.3)
$50,000–$75,000 1 (6.3) 1 (7.1) 2 (6.7) 75 (12.1)
$75,000–$99,999 0 0 28 (4.5)
>$100,000 0 (0.0) 1 (7.1) 1 (3.3) 19 (3.1)
No response 7 (43.8) 5 (35.7) 12 (40.0) 95 (15.3)
NOURISH, nutrition effect on unplanned readmission and survival in hospitalized patients; NSD, no significant difference; SEM, standard error
of the mean; S-ONS, specialized oral nutrition supplement.
aP-values reflect difference between placebo and S-ONS groups; significance was set at P < .05.
patients receiving S-ONS (vs placebo) met the DRI at
all time points for linolenic acid, calcium, magnesium,
phosphorus, zinc, copper, vitamin E, vitamin C, thiamin,
and folate. In fact, all patients in the S-ONS group met
the RDA for iron, phosphorus, copper, selenium, thiamin,
and riboflavin with supplement consumption. At 90 days,
the percentage of patients meeting the DRI was not differ-
ent between placebo and S-ONS groups for dietary fiber,
added sugars, potassium, sodium, vitamin D, riboflavin, or
vitamin K.
Relationship Between Patient Supplement
Consumption and Number of DRIs Met
Regression analysis, accounting for repeated measurements
per subject, of supplement intake vs number of DRIs met
is displayed in Figure 2. Regardless of day, higher patient
compliance (ie, consumption of S-ONSs per day) was
associated with a higher number of DRIs met (regression
coefficient, β = 4.46, P = .0002), whereas there was no
significant relationship for the placebo group (β = 1.21,
P = .41).
Power Analysis for Individual Nutrients
Results of the power analysis for the 16 nutrients found not
to be significantly different between treatment groups at day
90 from food alone are displayed in Table 3. Number of
patients needed to adequately power future studies in this
population ranged from 22 (riboflavin) to 802 (vitamin K).
Standardized effect sizes ranged from 0.140 (vitamin K) to
0.88 (riboflavin).
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Figure 1. Specialized oral nutrition supplement (S-ONS) improves overall macronutrient consumption profile. Boxes represent
interquartile range with median as the middle (horizontal line). Recommended intake is represented by dashed lines.
Macronutrients included (A) total kilocalories, (B) protein, (C) total fat, (D) saturated fat, (E) linoleic acid, (F) linolenic acid,
(G) total carbohydrate, (H) added sugars, and (I) dietary fiber. Significant difference between placebo and S-ONS (food +
S-ONS): *P < .05; **P < .01. RDA, recommended dietary allowance.
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Table 2. Percentage of DRI Met From Food Alone or With S-ONS by Time and Treatment.
Percentage of DRI Met, Median (1st quartile, 3rd quartile) Effect, P-Valuea
Nutrients Day PL (Food) S-ONS (Food)
S-ONS
(Food + S-ONS) PL vs S-ONS (Food)
PL vs S-ONS
(Food + ONS)
Calcium 30 34.3 (24.6, 63.7) 44.3 (29.8, 63.4) 109.0 (90.2, 139.0) .6157 S-ONS > PL: P < .0001
60 39.3 (35.4, 52.4) 50.0 (37.0, 85.0) 125.9 (119.7, 144.3) .2778 S-ONS > PL: P = .0003
90 47.8 (22.3, 57.2) 49.9 (47.9, 98.0) 130.4 (110.5, 144.0) .1286 S-ONS > PL: P = .0004
Iron 30 130.6 (96.5, 189.0) 129.5 (89.1, 172.2) 216.82 (165.0, 266.1) .6157 S-ONS > PL: P = .0107
60 128.1 (110.3, 224.2) 145.8 (125.6, 201.2) 242.0 (202.7, 298.1) .2778 S-ONS > PL: P = .0101
90 128.6 (73.4, 210.8) 194.8 (182.3, 223.4) 290.4 (269.1, 335.9) S-ONS > PL: P = .0334 S-ONS > PL: P = .0006
Magnesium 30 48.0 (41.9, 53.7) 47.5 (31.4, 63.7) 88.3 (80.0, 111.4) .9131 S-ONS > PL: P = .0001
60 48.8 (41.1, 61.3) 73.2 (43.7, 75.2) 121.1 (96.5, 126.0) .0586 S-ONS > PL: P = .0003
90 40.4 (34.1, 65.5) 64.0 (58.3, 75.8) 111.4 (90.6, 124.3) S-ONS > PL: P = .0402 S-ONS > PL: P = .0002
Phosphorus 30 121.5 (77.7, 164.4) 109.8 (100.8, 157.3) 192.9 (163.7, 242.3) .9131 S-ONS > PL: P = .0024
60 129.4 (88.3, 164.1) 142.2 (110.6, 190.3) 241.4 (195.6, 285.0) .2036 S-ONS > PL: P = .0014
90 80.6 (51.3, 152.0) 146.6 (129.2, 185.9) 231.6 (204.4, 284.4) S-ONS > PL: P = .0276 S-ONS > PL: P = .0006
Potassium 30 42.5 (28.6, 51.6) 36.7 (29.3, 49.1) 56.2 (45.8, 74.4) .7107 S-ONS > PL: P = .0154
60 35.4 (31.4, 58.0) 41.8 (33.5, 47.3) 63.2 (47.1, 72.2) .9259 S-ONS > PL: P = .0277
90 33.1 (25.0, 54.3) 40.13 (39.0, 55.8) 60.5 (55.0, 65.2) .3233 S-ONS > PL: P = .0018
Sodium 30 89.0 (64.3, 135.2) 92.6 (77.2, 127.5) 105.3 (89.7, 144.8) 1 .2475
60 91.4 (81.4, 164.6) 103.6 (64.4, 128.5) 111.3 (85.3, 146.8) .5558 .7802
90 90.3 (45.1, 140.8) 97.4 (47.9, 140.5) 118.2 (67.2, 147.0) .8792 .4474
Zinc 30 99.8 (67.1, 119.5) 71.1 (56.1, 111.4) 339.3 (240.2, 421.4) .2301 S-ONS > PL: P < .0001
60 93.1 (73.2, 111.3) 91.0 (55.4, 116.6) 387.7 (359.6, 461.1) .9259 S-ONS > PL: P = .0006
90 61.9 (49.7, 79.0) 111.7 (96.9, 133.7) 431.2 (369.7, 473.3) S-ONS > PL: P = .0062 S-ONS > PL: P = .0002
Copper 30 96.1 (65.9, 138.0) 89.7 (60.2, 107.9) 194.5 (151.0, 246.7) .5854 S-ONS > PL: P = .0006
60 101.4 (73.7, 144.0) 110.6 (84.6, 124.7) 228.1 (170.4, 263.6) .6869 S-ONS > PL: P = .0006
90 87.8 (51.0, 112.9) 113.8 (102.9, 161.8) 250.4 (199.4, 300.7) S-ONS > PL: P = .0482 S-ONS > PL: P = .0003
Manganese 30 107.9 (71.8, 127.5) 126.5 (59.3, 163.0) 164.1 (111.5, 215.1) .4715 S-ONS > PL: P = .0154
60 130.2 (73.0, 162.4) 150.3 (71.5, 181.5) 207.7 (134.8, 239.8) .5981 .0586
90 74.2 (61.0, 132.3) 153.1 (129.6, 182.0) 195.7 (163.1, 234.1) S-ONS > PL: P = .0276 S-ONS > PL: P = .0039
Selenium 30 149.0 (96.6, 230.9) 160.2 (112.3, 183.1) 243.3 (172.4, 262.0) .9131 S-ONS > PL: P = .0094
60 159.0 (97.7, 187.2) 150.1 (131.8, 185.0) 237.5 (206.1, 276.3) .7802 S-ONS > PL: P = .0143
90 111.0 (76.3, 170.9) 194.8 (146.0, 222.8) 279.8 (243.9, 321.1) S-ONS > PL: P = .0098 S-ONS > PL: P = .0008
Vitamin A 30 59.6 (47.7, 136.1) 74.6 (33.7, 95.1) 124.4 (95.3, 173.1) .3261 S-ONS > PL: P = .0307
60 67.2 (33.3, 78.5) 80.0 (43.4, 106.6) 154.8 (115.0, 163.9) .3062 S-ONS > PL: P = .0026
90 65.2 (46.8, 84.2) 119.2 (94.9, 138.1) 167.8 (154.8, 223.1) S-ONS > PL: P = .0098 S-ONS > PL: P = .0004
Vitamin E 30 36.2 (19.1, 54.3) 28.9 (22.3, 48.4) 578.1 (382.3, 635.9) .7434 S-ONS > PL: P < .0001
60 37.0 (20.1, 73.6) 48.0 (39.5, 60.5) 635.8 (446.0, 646.7) .2512 S-ONS > PL: P < .0001
90 39.3 (24.9, 53.1) 54.8 (36.5, 79.4) 625.7 (564.8, 660.0) .1106 S-ONS > PL: P = .0002
Vitamin D 30 20.2 (13.4, 34.0) 18.9 (11.5, 42.4) 69.1 (46.7, 93.7) .7434 S-ONS > PL: P = .0002
60 19.9 (12.1, 26.3) 28.9 (12.9, 45.3) 76.5 (60.4, 94.7) .3364 S-ONS > PL: P = .0017
90 14.3 (4.7, 27.6) 27.6 (18.4, 54.0) 72.1 (69.7, 83.9) .0946 S-ONS > PL: P = .0004
Vitamin Cb 30 55.2 (34.1, 87.9) 75.2 (27.8, 142.1) 211.0 (150.3, 246.3) .6157 S-ONS > PL: P = .0010
60 51.8 (26.9, 81.6) 67.7 (24.9, 163.0) 186.5 (174.1, 242.3) .5558 S-ONS > PL: P = .0017
90 39.3 (23.7, 71.0) 85.4 (42.2, 111.6) 208.3 (165.5, 257.9) .1965 S-ONS > PL: P = .0033
Thiamin 30 92.3 (65.9, 146.2) 94.7 (78.9, 125.1) 156.9 (132.5, 178.7) .7107 S-ONS > PL: P = .0032
60 112.1 (79.4, 129.6) 117.4 (92.6, 139.4) 175.8 (124.9, 196.6) .5558 S-ONS > PL: P = .0026
90 111.5 (55.3, 134.9) 134.1 (103.6, 145.4) 171.5 (160.2, 208.7) .1489 S-ONS > PL: P = .0011
Riboflavin 30 130.3 (91.8, 222.9) 121.3 (84.5, 172.3) 170.8 (155.0, 234.6) .5557 .0847
60 149.6 (116.6, 167.4) 135.7 (105.2, 196.2) 206.1 (169.3, 264.6) .9259 S-ONS > PL: P = .0279
90 139.7 (96.3, 157.6) 183.8 (158.2, 245.4) 249.9 (202.4, 290.6) .0575 S-ONS > PL: P = .0018
Niacin 30 103.6 (70.2, 144.0) 102.1 (76.5, 142.9) 154.3 (132.0, 205.2) .8443 S-ONS > PL: P = .0275
60 95.7 (76.5, 142.5) 131.2 (113.4, 140.6) 179.1 (171.2, 188.9) .2036 S-ONS > PL: P = .0017
90 114.5 (47.1, 123.2) 116.1 (103.5, 131.0) 174.4 (137.2, 201.2) .2545 S-ONS > PL: P = .0008
Vitamin B6 30 96.8 (63.1, 127.1) 72.8 (47.4, 98.5) 119.9 (99.2, 146.3) .2849 S-ONS > PL: P = .0343
60 97.3 (47.9, 107.7) 82.8 (69.9, 116.1) 143.3 (114.8, 161.6) .5981 S-ONS > PL: P = .0039
90 87 (34.9, 108.4) 107.4 (81.0, 122.2) 146.5 (127.0, 183.8) .2875 S-ONS > PL: P = .0024
Vitamin B12 30 117.6 (86.1, 255.0) 102.9 (86.9, 169.6) 328.2 (269.7, 416.3) .4987 S-ONS > PL: P = .0011
60 147.0 (105.3, 218.5) 143.1 (110.2, 199.3) 369.4 (307.8, 400.7) .6869 S-ONS > PL: P = .0032
90 101.3 (55.5, 221.4) 224.2 (135.6, 273.5) 450.6 (348.1, 523.5) S-ONS > PL: P = .0402 S-ONS > PL: P = .0004
Choline 30 53.2 (40.5, 92.6) 44.4 (36.0, 60.0) 71.6 (60.8, 90.8) .2301 .1831
60 41.0 (34.1, 77.2) 44.6 (36.0, 71.1) 77.0 (66.2, 110.2) .5981 S-ONS > PL: P = .0438
90 42.1 (29.9, 51.4) 69.5 (53.4, 78.6) 101.8 (83.6, 108.7) S-ONS > PL: P = .0334 S-ONS > PL: P = .0008
Vitamin K 30 49.9 (34.5, 102.1) 41.2 (19.4, 61.7) 69.4 (48.6, 106.2) .1692 .2301
60 62.3 (30.5, 77.5) 61.8 (51.3, 86.5) 97.9 (87.6, 122.2) .4025 S-ONS > PL: P = .0236
90 63.5 (47.3, 182.9) 71.4 (45.9, 103.4) 104.7 (84.8, 122.2) .9394 .1965
(continued)
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Table 2. (continued)
Percentage of DRI Met, Median (1st quartile, 3rd quartile) Effect, P-Valuea
Nutrients Day PL (Food) S-ONS (Food)
S-ONS
(Food + S-ONS) PL vs S-ONS (Food)
PL vs S-ONS
(Food + ONS)
Folate 30 86.2 (62.1, 122.3) 104.0 (74.7, 113.7) 228.2 (198.3, 280.3) .5557 S-ONS > PL: P < .0001
60 105.8 (74.5, 141.0) 113.2 (77.5, 118.6) 242.4 (208.6, 287.0) .8768 S-ONS > PL: P = .0002
90 81.9 (64.7, 124.8) 126.7 (109.0, 187.9) 277.5 (225.9, 355.1) .0682 S-ONS > PL: P = .0004
DRI, Dietary Reference Intake; ONS, oral nutrition supplement; PL, placebo; S-ONS, specialized oral nutrition supplement.
aSignificance was set at P < .05.



























Figure 2. Increased compliance to specialized oral nutrition
supplement (S-ONS) consumption, but not placebo, is
associated with meeting more Dietary Reference Intakes
(DRIs), regardless of time point. Time points were pooled
within treatment groups after no significant differences in
regression slopes were found. Relationships were tested via
repeated-measures analysis. S-ONS group: P = .0002, β =
4.46; placebo group: P = .41, β = 1.21. Black triangles
indicate day 30; squares indicate day 60; circles indicate day
90; gray-filled shapes represent S-ONS; white-filled shapes
represent placebo.
Discussion
This study highlights the effectiveness of using S-ONSs to
improve daily macronutrient and micronutrient intake in
malnourished older adult patients with cardiopulmonary
diseases after hospital discharge. The results suggest that
an S-ONS, when consumed between meals, does not reduce
intake of nutrients from food; in fact, it increases intake
of some food-derived micronutrients, while concurrently
improving overall diet quality. It may take a longer time (eg,
Table 3. Number of Patients Required to Detect Differences
in Standardized Effect Sizes of Percentage of Dietary









Dietary fiber (g) 19.7 0.49 68
Added sugars (% kcal) 3.98 0.47 73
Total fat (% kcal) 8.14 0.69 35
Linoleic acid (g) 50.9 0.34 137
Linolenic acid (g) 43.6 0.56 52
Calcium (mg) 30.5 0.78 27
Potassium (mg) 14.1 0.52 60
Vitamin E (mg) 31.5 0.82 25
Vitamin D (mcg) 20.9 0.71 32
Vitamin C (mg) 53.9 0.46 74
Thiamin (mg) 40.7 0.66 37
Riboflavin (mg) 64.4 0.88 22
Niacin (mg) 35.4 0.73 31
Vitamin B6 (mg) 36.1 0.60 45
Vitamin K (mcg) 162 0.14 802
Folate (mcg) 53.5 0.83 24
3 months) of S-ONS therapy for some changes in dietary
patterns to become evident.
This study emphasizes the nutrition deficits in patients
with cardiopulmonary diseases post discharge, and how a
majority of these needs can be met with daily ONS intake
in conjunction with normal food intake. The notion that nu-
trient intake should be consumed primarily from food, with
nutrition supplements serving only as a secondary source
or stopgap, should be reconsidered; encouraging intake of
both food and ONSs can fill the gaps in macronutrient and
micronutrient intake. As shown in this study, some patients
still had gaps of certain nutrients even with the ONS
consumption.Hence it is not one or the other; both food and
ONSs need to be considered when addressing the nutrition
needs of the individual. Overall diet quality was improved
via S-ONSs in several respects, while maintaining (days 30
and 60) or increasing (day 90) total energy consumed. First,
nutrients of concern for overconsumption in this high-risk
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population, such as added sugars and sodium, were not
increased, and percent calories from saturated fat intake was
lower in the group consuming S-ONS. Second, consumption
of protein and practically all micronutrients was higher in
the S-ONS group 90 days after discharge. Finally, higher
compliance to the recommendation of consuming 2 S-
ONSs per day was associated with patients meeting more
nutrient intake goals. However, 0 or very few patients met
recommendations for dietary fiber, magnesium, potassium,
or vitamin D at any time point included in this study,
indicating that there is a role for dietary counseling to
improve intake of these key nutrients from food, and that
future nutrition supplements can be improved to address
these gaps as well. Dietary interventions should consider
both food and ONSs to achieve optimal nutrient intake in
patients who are at increased risk for malnutrition.
Small sample size is a weakness of this study, yet it did
not hamper our ability to detect differences in consumption
for the majority of nutrients. This subgroup of patients
had better compliance to ONS intake compared with other
studies,29 which allowed us to demonstrate the positive
impact of ONS consumption, because our data indicate
that higher compliance is related to meeting more nutrient
intake goals. In addition, results from this study lay the
groundwork for future studies by providing the estimated
number of patients needed to investigate specific nutrients
in this population. Our power analyses suggest that some
nutrients may be more difficult to study in this context,
given that >100 patients would need to be followed in this
great amount of detail to make an adequately powered
comparison between groups. However, the biological and
clinical relevance of small effect sizes observed for some
nutrients in this study should be considered when designing
future studies. This study used a validated method, 3-day
dietary recall, to estimate nutrient intake. As with all self-
reported estimates of dietary intake, there is a tendency for
misreporting, typically underreporting of intake. Much of
the error in dietary recall is due to errors in memory, portion
size estimation, and day-to-day variation in intake, all of
which may impact on dietary outcomes. Using standardized
multiple-pass methodology, intake data from 3 randomly
selected days, and portion size estimation tools (as were used
in this trial) may significantly reduce the extent to which
these errors occur.30-32
A strength of this study lies in its longitudinal collection
of consumption data for all nutrients with an RDA. These
data demonstrate the need for long-term follow-up with
this population to monitor changes in nutrition adequacy.
No differences in nutrient intake from food alone were
detected between groups before 90 days of intervention (as
both percent DRI met and proportion of patients meeting
DRIs), and 37% more nutrients had a higher percentage
of patients meeting the DRI after 90 days of treatment
(compared with 30 days). Although this study used DRI
as the nutrition goalpost for these patients, it is important
to remember that these dietary guidelines are designed for
healthy individuals, and nutrient requirements may differ
for patients with cardiopulmonary diseases. Future studies
should also strive to collect biomarkers confirming nutrition
status in a larger patient population, which will contribute
to setting nutrient recommendations for this population.
In conclusion, S-ONS intake increases oral nutrient
intake to help meet most nutrient requirements without de-
creasing nutrient intake from food in malnourished clinical
populations.
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